This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Orazi A . Quantification of marrow CD34+ cells: an important tool for distinguishing between hypoplastic myelodysplastic syndromes and aplastic anemia. Leukemia 2006.
Matsui WH, Brodsky RA, Smith BD, Borowitz MJ, Jones RJ . Quantitative analysis of bone marrow CD34 cells in aplastic anemia and hypoplastic myelodysplastic syndromes. Leukemia 2006; 20: 458–462.
Orazi A, Albitar M, Heerema NA, Haskins S, Neiman RS . Hypoplastic myelodysplastic syndromes can be distinguished from acquired aplastic anemia by CD34 and PCNA immunostaining of bone marrow biopsy specimens. Am J Clin Pathol 1997; 107: 268–274.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Matsui, W., Brodsky, R., Smith, B. et al. Reply to ‘Quantification of marrow CD34+ cells: an important tool for distinguishing between hypoplastic myelodysplastic syndromes and aplastic anemia’ by A Orazi. Leukemia 20, 2041–2042 (2006). https://doi.org/10.1038/sj.leu.2404394
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404394
This article is cited by
-
Reply to Matsui et al.
Leukemia (2006)